Nitroxoline resistance is associated with significant fitness loss and diminishes in vivo virulence of Escherichia coli.

ABSTRACT:

Importance

Antimicrobial resistance (AMR) poses a global threat and requires the exploration of underestimated treatment options. Nitroxoline, an effective broad-spectrum antibiotic, does not suffer from high resistance rates in the clinics but surprisingly, it is not heavily used yet. Our findings provide compelling evidence that Nitroxoline resistance renders bacteria unable to cause an infection in vivo, thereby reinvigorating the potential of Nitroxoline in combating AMR.

SUBMITTER: Deschner F 

PROVIDER: S-EPMC10782962 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature